Jiangxi Hemei Pharmaceutical Co., Ltd – Trademark Portfolio
Entity Type: 99
Jiangxi Hemei Pharmaceutical Co., Ltd holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BOTASUN, WOSCHON, and BEILLOSO. The owner is based in Zhangshu City.
4th Floor, Building 1956, Zhangjiashan Pharmaceutical
Incubation Park Phase III, Zhangshu City
Zhangshu City 331200 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jiangxi Hemei Pharmaceutical Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Jiangxi Hemei Pharmaceutical Co., Ltd have?
Jiangxi Hemei Pharmaceutical Co., Ltd has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Jiangxi Hemei Pharmaceutical Co., Ltd file in?
Jiangxi Hemei Pharmaceutical Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Jiangxi Hemei Pharmaceutical Co., Ltd's most well-known trademarks?
Jiangxi Hemei Pharmaceutical Co., Ltd's registered trademark portfolio includes well-known marks such as BOTASUN, WOSCHON, and BEILLOSO. These are among 3 currently registered trademarks in the portfolio.
What is Jiangxi Hemei Pharmaceutical Co., Ltd's trademark registration success rate?
Jiangxi Hemei Pharmaceutical Co., Ltd has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.